Driving business growth through innovative food and nutrition strategies for CPG & foodservice brands. 💡 The Rise of GLP-1 ...

Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

So can he run again? Helping out the First Buddy: Musk’s Tesla stock soars after reports Trump will ease rules on driverless cars Doctors worry about RFK Jr’s anti-Ozempic stance (and many of his ...

As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.

Kennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...

Police looking for thieves who stole weight loss drugs from pharmacies in Dearborn, Dearborn Heights ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

As GLP-1 drugs like Ozempic soar in popularity for weight loss, this film follows three people on their own GLP-1 journeys and explores how decades of diet culture and society’s relentless pursuit of ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Here’s the synopsis: As GLP-1 drugs like Ozempic soar in popularity for weight loss, this film follows three people on their ...